Should we measure serum or plasma lead concentrations?

Journal of Trace Elements in Medicine and Biology

Volumn 24, Issue 3, 2010, Pages 147-151

  Rezende, Vania B ^a   Amaral, Jefferson H ^b   Gerlach, Raquel F ^b   Barbosa, Fernando ^c   Tanus Santos, Jose E ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Faculty of Pharmaceutical Sciences of Ribeirao Preto   (Brazil)

Author keywords

Lead; Plasma; Serum

Indexed keywords

EDETIC ACID; HEMOGLOBIN; HEPARIN; LEAD;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; LEAD BLOOD LEVEL; MASS SPECTROMETRY; NORMAL HUMAN; PHLEBOTOMY; PRIORITY JOURNAL;

ADULT; BLOOD SPECIMEN COLLECTION; EDETIC ACID; HUMANS; LEAD; PLASMA; SERUM; SPECTROPHOTOMETRY, ATOMIC; TIME FACTORS; YOUNG ADULT;

EID: 77953543703     PISSN: 0946672X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtemb.2010.01.008     Document Type: Article

References (27)

1. Banks E.C., Ferretti L.E., Shucard D.W. Effects of low level lead exposure on cognitive function in children: a review of behavioral, neuropsychological and biological evidence. Neurotoxicology 1997, 18(1):237-281.
2. Barbosa F., Sartorio J.T.C., Gerlach R.F., Tanus-Santos J.E. Clinical evidence for lead-induced inhibition of nitric oxide formation. Archives of Toxicology 2006, 80:811-816.
3. Barbosa F., Gerlach R.F., Tanus-Santos J.E. Matrix metalloproteinase-9 activity in plasma correlates with plasma and whole blood lead concentrations. Basic & Clinical Pharmacology & Toxicology 2006, 98(6):559-564.
4. Barbosa F., Sandrim V.C., Uzuelli J.A., Gerlach R.F., Tanus-Santos J.E. eNOS genotype-dependent correlation between whole blood lead and plasma nitric oxide products concentrations. Nitric Oxide 2006, 14:58-64.
5. ATSDR. Toxicological Profile for Lead. Atlanta, Ga: US Department of Health and Human Services, Public Health Services, 1999.
6. Barbosa F., Tanus-Santos J.E., Gerlach R.F., Parsons P.J. A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs. Environmental Health Perspectives 2005, 113(12):1669-1674.
7. Gulson B.L., Jameson C.W., Mahaffey K.R., Mizon K.J., Korsch M.J., Vimpani G. Pregnancy increases mobilization of lead from maternal skeleton. Journal of Laboratory and Clinical Medicine 1997, 130(1):51-62.
8. Smith D., Hernandez-Avila M., Tellez-Rojo M.M., Mercado A., Hu H. The relationship between lead in plasma and whole blood in women. Environmental Health Perspectives 2002, 110(3):263-268.
9. Montenegro M.F., Barbosa F., Tanus-Santos J.E. Assessment of how pregnancy modifies plasma lead and plasma/whole blood lead ratio in ALAD 1-1 genotype women. Basic & Clinical Pharmacology & Toxicology 2008, 102(4):347-351.
10. Hu H., Shih R., Rothenberg S., Schwartz B.S. The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues. Environmental Health Perspectives 2007, 115(3):455-462.
11. Hu H., Tellez-Rojo M.M., Bellinger D., Smith D., Ettinger A.S., Lamadrid-Figueroa H., Schwartz J., Schnaas L., Mercado-Garcia A., Hernandez-Avila M. Fetal lead exposure at each stage of pregnancy as a predictor of infant mental development. Environmental Health Perspectives 2006, 114(11):1730-1735.
12. Schnaas L., Rothenberg S.J., Flores M.F., Martinez S., Hernandez C., Osorio E., Velasco S.R., Perroni E. Reduced intellectual development in children with prenatal lead exposure. Environmental Health Perspectives 2006, 114(5):791-797.
13. Bergdahl I.A., Skerfving S. Biomonitoring of lead exposure-alternatives to blood. Journal of Toxicology and Environmental Health 2008, 71(18):1235-1243.
14. Bergdahl I.A., Gerhardsson L., Liljelind I.E., Nilsson L., Skerfving S. Plasma-lead concentration: investigations into its usefulness for biological monitoring of occupational lead exposure. American Journal of Industrial Medicine 2006, 49(2):93-101.
15. Bergdahl I.A., Schutz A., Gerhardsson L., Jensen A., Skerfving S. Lead concentrations in human plasma, urine and whole blood. Scandinavian Journal of Work, Environment & Health 1997, 23(5):359-363.
16. Cornelis R., Heinzow B., Herber R.F., Christensen J.M., Poulsen O.M., Sabbioni E., Templeton D.M., Thomassen Y., Vahter M., Vesterberg O. Sample collection guidelines for trace elements in blood and urine. Pure and Applied Chemistry 1995, 67:1575-1608.
17. Smith D.R., Ilustre R.P., Osterloh J.D. Methodological considerations for the accurate determination of lead in human plasma and serum. American Journal of Industrial Medicine 1998, 33(5):430-438.
18. Rezende V.B., Barbosa F., Montenegro M.F., Sandrim V.C., Gerlach R.F., Tanus-Santos J.E. Haplotypes of vitamin D receptor modulate the circulating levels of lead in exposed subjects. Archives of Toxicology 2008, 82(1):29-36.
19. Montenegro M.F., Barbosa F., Sandrim V.C., Gerlach R.F., Tanus-Santos J.E. A polymorphism in the delta-aminolevulinic acid dehydratase gene modifies plasma/whole blood lead ratio. Archives of Toxicology 2006, 80(7):394-398.
20. Gulson B.L., Mahaffey K.R., Jameson C.W., Mizon K.J., Korsch M.J., Cameron M.A., Eisman J.A. Mobilization of lead from the skeleton during the postnatal period is larger than during pregnancy. Journal of Laboratory and Clinical Medicine 1998, 131(4):324-329.
21. Bergdahl I.A., Vahter M., Counter S.A., Schutz A., Buchanan L.H., Ortega F., Laurell G., Skerfving S. Lead in plasma and whole blood from lead-exposed children. Environmental Research 1999, 80(1):25-33.
22. Gulson B.L., Jameson C.W., Mahaffey K.R., Mizon K.J., Korsch M.J., Vimpani G. Pregnancy increases mobilization of lead from maternal skeleton. Journal of Laboratory and Clinical Medicine 1997, 130(1):51-62.
23. Gulson B.L., Mizon K.J., Korsch M.J., Palmer J.M., Donnelly J.B. Mobilization of lead from human bone tissue during pregnancy and lactation--a summary of long-term research. Science of the Total Environment 2003, 303(1-2):79-104.
24. Hu H., Rabinowitz M., Smith D. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environmental Health Perspectives 1998, 106(1):1-8.
25. Rabinowitz M.B. Toxicokinetics of bone lead. Environmental Health Perspectives 1991, 91:33-37.
26. Schutz A., Bergdahl I.A., Ekholm A., Skerfving S. Measurement by ICP-MS of lead in plasma and whole blood of lead workers and controls. Occupational and Environmental Medicine 1996, 53(11):736-740.
27. deSilva P.E. Determination of lead in plasma and studies on its relationship to lead in erythrocytes. British Journal of Industrial Medicine 1981, 38(3):209-217.